- Abstract:
-
BACKGROUND: Population mean changes from clinical trials are difficult to apply to individuals in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. METHODS: The numbers of patients with pain relief over baseline (> or =15%, > or =30%, > or =50%, > or =70%) at 2, 4, 8 and 12 weeks of treatment were obtained using the WOMAC 100 mm visual analogue pain subscale score for each treatment group in seven randomised pl...
Expand abstract - Publication status:
- Published
- Journal:
- Annals of the rheumatic diseases
- Volume:
- 69
- Issue:
- 2
- Pages:
- 374-379
- Publication date:
- 2010-02-05
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- URN:
-
uuid:dfc795e5-c7ac-4ca7-ba4b-0a48531234c4
- Source identifiers:
-
241223
- Local pid:
- pubs:241223
- Copyright date:
- 2010
Journal article
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record